Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr-Jun;19(1):1-10.
doi: 10.22074/cellj.2016.4867. Epub 2016 Dec 21.

Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy

Affiliations
Review

Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy

Nazem Ghasemi et al. Cell J. 2017 Apr-Jun.

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease characterized by central nervous system (CNS) lesions that can lead to severe physical or cognitive disability as well as neurological defects. Although the etiology and pathogenesis of MS remains unclear, the present documents illustrate that the cause of MS is multifactorial and include genetic predisposition together with environmental factors such as exposure to infectious agents, vitamin deficiencies, and smoking. These agents are able to trigger a cascade of events in the immune system which lead to neuronal cell death accompanied by nerve demyelination and neuronal dysfunction. Conventional therapies for MS are based on the use of anti-inflammatory and immunomodulatory drugs, but these treatments are not able to stop the destruction of nerve tissue. Thus, other strategies such as stem cell transplantation have been proposed for the treatment of MS. Overall, it is important that neurologists be aware of current information regarding the pathogenesis, etiology, diagnostic criteria, and treatment of MS. Thus, this issue has been discussed according to recent available information.

Keywords: Cell Therapy; Demyelination; Etiology; Multiple Sclerosis.

PubMed Disclaimer

Figures

Fig.1
Fig.1
Immune cells and their cytokines which involved in the pathogenesis of multiple sclerosis (MS).

Similar articles

Cited by

References

    1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–1517. - PubMed
    1. Loma I, Heyman R. Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol. 2011;9(3):409–416. - PMC - PubMed
    1. Weiner HL. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol. 2008;255(Suppl 1):3–11. - PubMed
    1. Gadoth N. Multiple sclerosis in children. Brain Dev. 2003;25(4):229–232. - PubMed
    1. Boiko A, Vorobeychicle G, Paty D, Devonshire V, Sondovnick D. University of British Columbia MS Clinic Neurologists.Early onset multiple sclerosis: a long longitudinal study. Neurology. 2002;59(7):1006–1010. - PubMed

LinkOut - more resources